Depo-Provera Brain Tumor Lawsuits

Women who used Depo-Provera long-term and developed meningioma (brain tumor) may be entitled to compensation.

Overview

Recent studies suggest a potential link between long-term Depo-Provera (medroxyprogesterone acetate) use and an increased risk of meningioma, a type of brain tumor.

Key Facts

Active Cases: 130 cases as of March 2025
MDL Status: Newly formed, rapidly growing
Defendant: Pfizer (manufacturer of Depo-Provera)
Primary Condition: Meningioma (brain tumor)

Who Qualifies?

You may be eligible if you:

Used Depo-Provera birth control for extended periods (typically 1+ years)
Were diagnosed with meningioma (brain tumor)
Required surgery or treatment for the tumor
Experienced symptoms after prolonged use

What is Meningioma?

Meningioma is a tumor that:

Forms in the membranes surrounding the brain and spinal cord
Can be benign or malignant
Often requires surgical removal
Can cause serious neurological symptoms
May recur after treatment

Scientific Evidence

Recent studies show increased meningioma risk with long-term Depo-Provera use
Risk appears to increase with duration of use
Hormone-related mechanism suspected

Common Symptoms

Headaches
Vision problems
Seizures
Memory issues
Weakness or numbness
Hearing loss

Potential Damages

Medical expenses (surgery, treatment)
Lost wages and earning capacity
Pain and suffering
Neurological impairment
Reduced quality of life

Recent Developments

March 2025: MDL grew to 130 cases
Rapid Growth: New cases being filed as awareness increases
Early Stage: Litigation in initial phases

How to File

If you developed a brain tumor after long-term Depo-Provera use, contact us for a free, confidential case evaluation.